Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Bachem Holding AG

+ Add to Watchlist

BANB:SW

52.00 CHF 0.000.00%

As of 11:43:40 ET on 04/27/2015.

Snapshot for Bachem Holding AG (BANB)

Open: 52.00 Day's Range: 52.00 - 52.65 Volume: 8,107
Previous Close: 52.00 52wk Range: 41.55 - 54.00 1-Yr Rtn: +4.53%

Stock Chart for BANB

No chart data available.
  • BANB:SW 52.00
  • 1D
  • 1M
  • 1Y
52.00
Interactive BANB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BANB

Current P/E Ratio (ttm) 24.1860
Estimated P/E(12/2015) 23.3393
Relative P/E vs. SMI 1.2655
Earnings Per Share (CHF) (ttm) 2.1500
Est. EPS (CHF) (12/2015) 2.2280
Est. PEG Ratio -
Market Cap (M CHF) 707.20
Shares Outstanding (M) 6.80
30 Day Average Volume 8,248
Price/Book (mrq) 2.0141
Price/Sale (ttm) 3.8204
Dividend Indicated Gross Yield 3.85%
Cash Dividend (CHF) 1.1600
Dividend Ex-Date 04/29/2015
5 Year Dividend Growth -11.37%
Next Earnings Announcement 08/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BANB

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for BANB

Bachem Holding AG manufactures ingredients for pharmaceuticals, generic drugs, and research supplies. The Company produces peptides and amino-acids for medications and laboratory research, and prescription medicines that are no longer patent protected. Bachem sells its products to universities, and pharmaceutical and biotechnology companies.

Thomas FruehChairman-Mgmt Board/CEOStephan SchindlerCFO/Member Mgmt Board
Daniel ErneCTO/Member Mgmt BoardJose De ChastonayCMO/Member Mgmt Board
More Company Profile & Key Executives for BANB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil